Studies in non-small cell lung cancer identified cross-talk between AXL and epidermal growth factor receptor [67], suggesting the possibility of a similar interaction between FGFR3 and AXL in CLL. This evidence concerns the gene AXL and B-cell chronic lymphocytic leukemia.